SELL YOUR PRODUCTS
*mymedicalexpo  
English
video corpo

COVID-19 rapid diagnostic test ESPLINE® SARS-CoV-2
for antigensSARS-COV-2coronavirus

COVID-19 rapid diagnostic test
COVID-19 rapid diagnostic test
COVID-19 rapid diagnostic test
COVID-19 rapid diagnostic test
Add to favorites
Compare this product
 

Characteristics

Applications
COVID-19
Tested parameter
for antigens
Micro-organism
SARS-COV-2, coronavirus
Sample type
nasopharyngeal
Analysis mode
immunochromatographic, enzyme immunoassay, molecular

Description

ESPLINE SARS-CoV-2 is for in vitro diagnostic (IVD) use with immunochromatographic assay for the detection of SARS-CoV-2 antigen directly from nasopharyngeal swab fluid and is intended for use as an aid in the diagnosis of SARS-CoV-2 infection. ESPLINE SARS-CoV-2 is a cassette-style assay using a simple procedure without any special instruments. SARS-CoV-2 can be detected within 30 minutes. About SARS-CoV-2 The 2019 novel coronavirus infection disease (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1,2 In December 2019, the Health Commission of the City of Wuhan, Hubei Province, China, reported multiple pneumonia patients with unknown cause. On January 7th 2020, the World Health Organization (WHO) announced that the National Health Commission of China identified a new type of coronavirus, SARS-CoV-2.3 The WHO declared a COVID-19 pandemic on March 11th 2020 due to the worldwide spread of novel coronavirus infection.4

VIDEO

Other Fujirebio products

Infectious Diseases

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.